Bio-Synectics is an innovator charting new frontiers in delivery systems utilizing its proprietary nanoparticles technology.
About 40% of approved drugs in the market and 90% of new drug candidates being developed are said to have the problem of poor solubility. We work with pharmaceutical companies to address this challenge and also develop our own pipeline of incrementally modified drugs for better efficacy and patient convenience.
Many functional ingredients used for food and cosmetic products are also poorly soluble. We provide value added functional ingredients with benefits of better bioavailability, consumer friendly formulation, and enhanced stability of end products.